1. Home
  2. TNGX vs BRY Comparison

TNGX vs BRY Comparison

Compare TNGX & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • BRY
  • Stock Information
  • Founded
  • TNGX 2014
  • BRY 1909
  • Country
  • TNGX United States
  • BRY United States
  • Employees
  • TNGX N/A
  • BRY N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • BRY Oil & Gas Production
  • Sector
  • TNGX Health Care
  • BRY Energy
  • Exchange
  • TNGX Nasdaq
  • BRY Nasdaq
  • Market Cap
  • TNGX 317.4M
  • BRY 328.5M
  • IPO Year
  • TNGX N/A
  • BRY N/A
  • Fundamental
  • Price
  • TNGX $1.95
  • BRY $3.38
  • Analyst Decision
  • TNGX Strong Buy
  • BRY Hold
  • Analyst Count
  • TNGX 7
  • BRY 1
  • Target Price
  • TNGX $12.33
  • BRY $5.00
  • AVG Volume (30 Days)
  • TNGX 817.7K
  • BRY 951.9K
  • Earning Date
  • TNGX 05-07-2025
  • BRY 03-12-2025
  • Dividend Yield
  • TNGX N/A
  • BRY 10.36%
  • EPS Growth
  • TNGX N/A
  • BRY N/A
  • EPS
  • TNGX N/A
  • BRY 0.25
  • Revenue
  • TNGX $42,069,000.00
  • BRY $783,841,000.00
  • Revenue This Year
  • TNGX N/A
  • BRY N/A
  • Revenue Next Year
  • TNGX N/A
  • BRY N/A
  • P/E Ratio
  • TNGX N/A
  • BRY $13.50
  • Revenue Growth
  • TNGX 15.17
  • BRY N/A
  • 52 Week Low
  • TNGX $1.72
  • BRY $3.06
  • 52 Week High
  • TNGX $12.02
  • BRY $8.88
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 37.66
  • BRY 34.29
  • Support Level
  • TNGX $1.80
  • BRY $3.39
  • Resistance Level
  • TNGX $2.01
  • BRY $3.89
  • Average True Range (ATR)
  • TNGX 0.21
  • BRY 0.23
  • MACD
  • TNGX 0.01
  • BRY -0.04
  • Stochastic Oscillator
  • TNGX 31.94
  • BRY 27.00

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About BRY Berry Corporation (bry)

Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.

Share on Social Networks: